ArticleInternational journal of general medicine2025
KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments.
Yangmin Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.